Cargando…
Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM
Aberrant expression of miR-211 has frequently been reported in cancer studies; however, its role in glioblastoma multiforme (GBM) has not been examined in detail. We investigated the function and the underlying mechanism of miR-211 in GBM. We revealed that miR-211 was downregulated in GBM tissues an...
Autores principales: | Li, Weidong, Miao, Xiaobo, Liu, Lingling, Zhang, Yue, Jin, Xuejun, Luo, Xiaojun, Gao, Hai, Deng, Xubin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421919/ https://www.ncbi.nlm.nih.gov/pubmed/28445937 http://dx.doi.org/10.18632/oncotarget.15531 |
Ejemplares similares
-
Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma
por: Chen, Yan, et al.
Publicado: (2019) -
Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2020) -
Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2022) -
Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling
por: Song, Yang, et al.
Publicado: (2019) -
TMEM2 induces epithelial-mesenchymal transition and promotes resistance to temozolomide in GBM cells
por: Gao, Lun, et al.
Publicado: (2023)